Dopamine-secreting pheochromocytomas: In search of a syndrome

World Journal of Surgery

Volumn 29, Issue 7, 2005, Pages 909-913

  Dubois, Luc A ^a   Gray, Daryl K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; HYPERTENSIVE FACTOR; METIROSINE; NORADRENALIN; PHENOXYBENZAMINE;

ABDOMINAL RADIOGRAPHY; ADRENALECTOMY; ADULT; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANAMNESIS; ANXIETY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIARRHEA; DOPAMINE RELEASE; FEMALE; HUMAN; HYPOTENSION; LABORATORY TEST; MEDICAL LITERATURE; PHEOCHROMOCYTOMA; PROGNOSIS; SEDATION; SIDE EFFECT; TREATMENT OUTCOME; ADRENAL TUMOR; BIOSYNTHESIS; METABOLISM; MIDDLE AGED;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; DOPAMINE; FEMALE; HUMANS; MIDDLE AGED; PHEOCHROMOCYTOMA;

EID: 27744498397     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-7860-7     Document Type: Article

References (20)

1. Ito Y, Fujimoto Y, Obara T. The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma. World J. Surg. 1992;16:759-764
2. Yanusari K, Kohno M, Minami M, et al. A dopamine-secreting pheochromocytoma. J. Cardiovasc. Pharmacol. 2000;36(Suppl. 2):S75-S77
3. Proye C, Fossati P, Fontaine P, et al. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 1986;100. 1154-1161
4. Bravo E. Pheochromocytoma. Cardiol. Rev. 2002;10:44-50
5. Jain SK, Agarwal N. Asymptomatic giant pheochromocytoma. J. Assoc. Physicians India 2002;50:842-844
6. Minamiguchi N, Inui E, Nukuy M. A case of dopamine secreting pheochromocytoma. Hinyokika Kiyo 1999;45:831-833
7. Jose PA, Eisner GM, Felder RA. Regulation of blood pressure by dopamine receptors. Nephron Physiol 2003;95:19-27
8. Pacak K, Linehan WM, Eisenhofer G, et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann. Intern. Med. 2001;134:315-329
9. 18F-labelled deoxyglucose. Eur. J. Surg. 2001;167:866-870
10. Sisson JC. Radiopharmaceutical treatment of pheochromocytomas. Ann. N.Y. Acad. Sci. 2002;970:54-60
11. Kolby L, Bernhardt P, Levin-Jakobsen AM, et al. Uptake of meta-iodobenzylguanidine in neuroendocrine tumors is mediated by vesicular monoamine transporters. Br. J. Cancer. 2003;89:1383-1388
12. Shulkin BL, Thompson NW, Shapiro B, et al. Pheochromocytomas: imaging with 2-[fluorine -18]fluoro-2-deoxy-d-glucose PET. Radiology 1999;212:35-41
13. 111In]octreotide uptake in benign and malignant pheochromocytomas. J. Clin. Endocrinol. Metab. 2001;86:685-693
14. Gray DK, Thompson NW. Pheochrornocytom In: Doherty, GM, Skogseid, B, Surgical Endocrinology. Philadelphia: Lippincott Williams & Wilkins, 2001, pp 247-261
15. Williams DT, Dann S, Wheeler MH. Phaeochromocytoma: views on current management. Eur. J. Surg. Oncol. 2003;29:483-490
16. John H, Ziegler WH, Hauri D, et al. Pheochromocytomas: can malignant potential be predicted? Urology 1999;53:679-683
17. Bravo EL. Pheochromocytoma: new concept and future trends. Kidney Int. 1991;40:544-556
18. Lack EE. Adrenal medullary hyperplasia and pheochromocytoma In: Lack, EE, Pathology of Adrenal and Extraadrenal Paraganglia: Major Problems in Pathology, vol. 29. Philadelphia: Saunders, 1994, pp 220-272
19. Tippet PA, McEwan AJ, Ackery DM. A re-evaluation of dopamine excretion in phaeochromocytoma. Clin. Endocrinol. (Oxf.) 1986;25:401-410
20. Feldman JM, Blalock JA, Zern RT, et al. Deficiency of dopamine-beta-hydroxylase; a new mechanism for normotensive pheochromocytomas. Am. J. Clin. Pathol. 1979;72:175-185